TORRENT PHARMACEUTICALS
Back to Income Statement
|
TORRENT PHARMACEUTICALS Last 5 Year Total Expenditure History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Expenditure | ₹7,364 Cr | ₹6,796 Cr | ₹6,077 Cr | ₹5,524 Cr | ₹5,769 Cr |
What is the latest Total Expenditure of TORRENT PHARMACEUTICALS ?
Year | Total Expenditure |
---|---|
Mar2025 | ₹7,364 Cr |
Mar2024 | ₹6,796 Cr |
Mar2023 | ₹6,077 Cr |
Mar2022 | ₹5,524 Cr |
Mar2021 | ₹5,769 Cr |
How is Total Expenditure of TORRENT PHARMACEUTICALS Trending?
Years | Total Expenditure | % Change | |
---|---|---|---|
Mar2025 | ₹7,364 Cr | 8.36 | |
Mar2024 | ₹6,796 Cr | 11.84 | |
Mar2023 | ₹6,077 Cr | 10.00 | |
Mar2022 | ₹5,524 Cr | -4.24 | |
Mar2021 | ₹5,769 Cr | - |
Compare Total Expenditure of peers of TORRENT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TORRENT PHARMACEUTICALS | ₹122,668.3 Cr | 3.5% | 8.4% | 16.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹408,595.0 Cr | 1.5% | 0.9% | 2% | Stock Analytics | |
DIVIS LABORATORIES | ₹174,635.0 Cr | -0.5% | -1.2% | 45.5% | Stock Analytics | |
CIPLA | ₹126,894.0 Cr | 7.2% | 4.5% | 2.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,373.0 Cr | 3.7% | -1.1% | -6.8% | Stock Analytics | |
MANKIND PHARMA | ₹104,885.0 Cr | -4.9% | 8.9% | 21.3% | Stock Analytics |
TORRENT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TORRENT PHARMACEUTICALS | 3.5% |
8.4% |
16.7% |
SENSEX | -1.6% |
-3.4% |
0.9% |
You may also like the below Video Courses